ÂÜÀòÂÒÂ×

Brandi Sails is a seasoned professional in biosample management with extensive experience in clinical operations, primarily in oncology and immunology. Currently serving as Senior Manager of Biosample Management at Nurix Therapeutics since June 2020, Brandi specializes in end-to-end biospecimen logistics for clinical trials. Prior roles include Manager of Clinical Biomarkers and Companion Diagnostics at Five Prime Therapeutics, Specialist II in Translational Development Operations at Celgene Corp, and Clinical Operations Associate at Synarc. Brandi's early career includes research roles at the University of California, San Francisco, and Burnham Cancer Institute. Brandi holds an MBA in International Business from Golden Gate University and a BA in Biology and Spanish from the University of San Diego, complemented by study abroad experience in Spain.